Who
James W. McCollum
Director
Company insider
Files Form 4 as: Director, LENZ Therapeutics.
In numbers
- Trades disclosed
- 10
- Buys
- 2
- Sells
- 0
- Bought
- $740K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 21 Mar 2024
- Last trade
- 15 Jun 2026
- Last filed
- 15 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Jun 2026filed 15 Jun 2026 | LENZ LENZ Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,100 at $0.00 | filing |
| 15 Jun 2026filed 15 Jun 2026 | LENZ LENZ Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,100 at $0.00 | filing |
| 7 Nov 2025filed 10 Nov 2025 | LENZ LENZ TherapeuticsBiotechnology | SEC FORM 4 Bought | $239K10,500 at $22.79 | filing |
| 11 Jun 2025filed 11 Jun 2025 | LENZ LENZ Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,500 at $0.00 | filing |
| 13 May 2024filed 14 May 2024 | LENZ LENZ TherapeuticsBiotechnology | SEC FORM 4 Bought | $501K31,332 at $15.99 | filing |
| 21 Mar 2024filed 25 Mar 2024 | LENZ LENZ Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,575 at $0.00 | filing |
| 21 Mar 2024filed 25 Mar 2024 | LENZ LENZ Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —27,000 at $0.00 | filing |
| 21 Mar 2024filed 25 Mar 2024 | LENZ LENZ TherapeuticsBiotechnology | SEC FORM 4 Code A | —95,034 at $0.00 | filing |
| 21 Mar 2024filed 25 Mar 2024 | LENZ LENZ TherapeuticsBiotechnology | SEC FORM 4 Code A | —477,600 at $0.00 | filing |
| 21 Mar 2024filed 25 Mar 2024 | LENZ LENZ TherapeuticsBiotechnology | SEC FORM 4 Code A | $250K16,633 at $15.03 | filing |
News
LENZ Therapeutics, Inc. (NASDAQ:LENZ) Stock Has Average Target Price of $28.80LENZ · dailypolitical.com · 20 Oct 2026
0 headlines in the last 90 days name James W. McCollum; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.